The present invention provides methods of determining cell sensitivity to a therapeutic agent.

An analytical and/or diagnostic device that includes a compartment for reagents stored within the device and uses surface energy gradient coatings to move liquid through fluid passages. The device can include a sampler for collecting a sample, a reaction region for reagents to react with the sample, and a detection region to detect any species of interest present in the sample.

A system and method for detecting harmful substances within a consumable sample comprising: receiving a consumable sample at a first chamber of a test container; transforming the consumable sample into a homogenized sample upon processing of the consumable sample; delivering the homogenized sample to a second chamber of the test container, wherein the second chamber is configured to receive the homogenized sample comprises an outlet port; mixing the homogenized sample with a process reagent within the second chamber, thereby producing a dispersion; transmitting a volume of the dispersion to an analysis chamber, of the test container, configured to position a detection substrate proximal the port of the second chamber and comprising a detection window that enables detection of presence of the allergen; and detecting presence of the allergen within the consumable sample by way of an optical sensor configured to detect signals indicative of the allergen through the detection window.

A self-contained apparatus and methods for detecting the presence of any specified substance in any medium. A sample of the medium is placed in a capsule, along with a solvent and a sensor configured to test for a target analyte. The solvent comes into contact with the medium in the capsule, and the capsule is agitated to create a dispersion in the solvent of a portion of any target analyte present in the medium. A release mechanism configured to cause conduction of the dispersion to the sensor, so that the sensor produces an indication of presence of the target analyte if the target analyte is present in the medium. The apparatus uses a disposable capsule where the medium in question is placed and the disposable capsule is placed inside a reader and analyzed for presence of the harmful substance.

A method for analyzing a biological fluid specimen. The collection cartridge is inserted into a reader. The plurality of reactive elements of the collection cartridge following insertion of the collection cartridge is optically read recurrently. The first color change of at least one reactive element of the collection cartridge is detected and dated following the recurrent optical reading. The biological fluid specimen from the collection cartridge is analyzed following the detection of the color change of at least one reactive element of the collection cartridge.

A method for determining an indicator of a bodily condition in an image of a bodily fluid testing equipment captured by an electronic device is provided. The method comprises determining colour data of a first bodily fluid testing region (109, 209) of a bodily fluid testing equipment (100, 200) from image data of the bodily fluid testing equipment, determining colour calibration data of at least one background sub-region (543) of a background region (545) of the bodily fluid testing equipment, calibrating the colour data based upon the determined colour calibration data, determining whether an indicator of a bodily condition has interacted with the first bodily fluid testing region, and providing an output, wherein the output is based upon whether the indicator of the bodily condition has interacted with the first bodily fluid testing region.

A test strip for urinalysis is provided, the test strip including a reagent pad for detecting a concentration of a selected analyte, the reagent pad attached to the test strip and comprising a substrate and an analyte detection system retained thereon, the analyte detection system including a plurality of components necessary for detection of the selected analyte, wherein at least one of the plurality of components is a variable component, the variable component immobilized on the substrate at a plurality of amounts on the reagent pad.

A test device includes a base holding at least one test strip in a plane. A buffer storage container is adjacent a first end of the test strip. A top of the buffer storage container is higher than the plane of the base. A frangible seal extends across the top of the buffer storage container. A transfer passage between the top of the buffer storage container and the first end of the test strip.

A method to manufacture a test strip for measuring specific gravity of a urine sample, the method including successively providing a polyelectrolyte in a first solution, the polyelectrolyte being poly(methyl vinyl ether-alt-maleic anhydride), adding to the first solution a base to neutralize the polyelectrolyte and to bring the first solution at a pH between 10 and 11, adding to the first solution a buffering agent to bring and maintain the first solution at a pH between 7.0 and 7.5, dipping a paper strip into the first solution, and dipping the paper strip into a second solution comprising a pH sensitive color indicator.

A lateral flow bodily fluid testing system is provided. The system comprises an application-analysable bodily fluid testing equipment (100, 200, 300) and an electronic device (1001) comprising a camera (1002) and one or more processors (1004). The one or more processors are configured to acquire image data of the application-analysable bodily fluid testing equipment with the camera of the electronic device, perform testing of bodily fluid applied to the application-analysable bodily fluid testing equipment using the image data to determine whether indicators of one or more bodily conditions are present in the applied bodily fluid, and output a result indicating whether the indicators of one or more bodily conditions are present in the applied bodily fluid.